VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside

Vascular endothelial growth factor (VEGF) pathway targeting agents have been combined with other anticancer drugs, leading to improved efficacy in carcinoma of the cervix, stomach, lung, colon and rectum, ovary, and breast. Vessel normalization induced by VEGF pathway targeting agents influences tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Arjaans, Marlous, Schröder, Carolina P., Oosting, Sjoukje F., Dafni, Urania, Kleibeuker, Josée E., de Vries, Elisabeth G.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008282/
https://www.ncbi.nlm.nih.gov/pubmed/26789111
http://dx.doi.org/10.18632/oncotarget.6918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008282/
https://www.ncbi.nlm.nih.gov/pubmed/26789111
http://dx.doi.org/10.18632/oncotarget.6918

Ejemplares similares